[Bone regeneration induced by stem cells--recent research and future outlook]

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Oral and Maxillofacial Surgery

Context:

• Alveolar bone resorption, resulting from periodontal diseases, trauma, or malignancies, necessitates bone regeneration for functional and aesthetic rehabilitation.
• Current surgical techniques like distraction osteogenesis, bone blocks, and guided bone regeneration (GBR) exhibit limitations in predictability and carry high morbidity.
• Tissue engineering presents an alternative, utilizing scaffolds, growth factors, and stem cells to regenerate large bone defects by mimicking craniofacial development.

Purpose:

• To review recent advancements and future prospects of using adult mesenchymal stem cells (MSC) and endothelial progenitor cells (EPC) for alveolar bone augmentation.
• To explore the potential of regenerative therapy in addressing severe bone resorption in periodontology, maxillofacial surgery, and implantology.

Summary:

• Alveolar bone resorption is a significant clinical challenge requiring effective regeneration strategies.
• Tissue engineering approaches, particularly those involving adult mesenchymal stem cells (MSC) and endothelial progenitor cells (EPC), are emerging as promising alternatives to conventional surgical methods.
• These regenerative therapies aim to induce bone augmentation by mimicking natural developmental processes, offering a new horizon for treating severe bone loss.

Impact:

• Regenerative therapy using stem cells holds the potential to revolutionize treatments for severe alveolar bone resorption.
• This approach may significantly improve patient rehabilitation outcomes in periodontology, maxillofacial surgery, and implantology.
• The integration of tissue engineering principles offers a more predictable and less invasive pathway for bone augmentation compared to existing surgical techniques.